IRulya Therapeutics Inc. (IRLA : NASDAQ)
Common Stock
Follow IRLA
IRLA
IRulya Therapeutics Inc.
WealthAwesomePerformance
1 Day
+14.34%
1 Week
+16.47%
1 Month
-
YTD
+19.20%
The Saturday TSX Wrap · free, every saturday morning. The week on the TSX, in five minutes.
Key Statistics
Market Cap
$366.17M
52W High
$910.00
52W Low
$15.10
P/E Ratio
-
50 Day MA
$31.00
200 Day MA
$38.92
Beta
1.79
Dividend Yield
-
Awesome Portfolio™
Looking past IRLA? Our 10 best Canadian stocks, in one list.
14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 11/10/2026 | $33.27 | $39.92 | $32.56 | $38.62 | $38.62 | 166,345 |
| 11/9/2026 | $29.50 | $35.12 | $29.50 | $33.77 | $33.77 | 125,236 |
| 11/6/2026 | $28.84 | $31.09 | $28.84 | $31.00 | $31.00 | 33,600 |
| 11/5/2026 | $30.47 | $30.91 | $27.03 | $29.31 | $29.31 | 53,364 |
| 11/4/2026 | $33.80 | $34.15 | $31.14 | $31.67 | $31.67 | 57,900 |
| 11/3/2026 | $32.95 | $33.55 | $31.85 | $33.16 | $33.16 | 60,326 |
| 11/2/2026 | $32.94 | $34.09 | $31.02 | $33.55 | $33.55 | 96,458 |
| 10/30/2026 | $30.67 | $34.40 | $30.00 | $32.95 | $32.95 | 98,000 |
| 10/29/2026 | $32.86 | $33.76 | $30.51 | $31.62 | $31.62 | 64,258 |
| 10/28/2026 | $32.32 | $33.40 | $31.00 | $32.95 | $32.95 | 63,079 |
Analyst Price Targets
Based on 8 analysts covering IRLA · as of Nov 9, 2026
Wall Street analysts forecast IRLA stock price to rise 94.2% over the next 12 months.
Consensus
Strong Buy4.75 / 5.00
Avg. Target
US$75.00
+94.2% Upside
Current Price
US$38.62
Last close
Analyst Breakdown (8 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
About IRulya Therapeutics Inc.
IRulya Therapeutics Inc., a biotechnology company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company's lead asset candidate comprises eDSP, which is in Phase 3 for the treatment of rare pediatric neurodegenerative diseases, including A-T, an inherited autosomal recessive neurodegenerative and immunodeficiency disorder caused by mutations in the ATM gene. Its AIDE technology platform is a drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells and consists of automated equipment, the RCL, a sterile single-use consumable treatment kit comprising medical device kits, syringe kits, and process solutions. IRulya Therapeutics Inc. was formerly known as Quince Therapeutics, Inc. and changed its name to IRulya Therapeutics Inc. in October 2026. The company was incorporated in 2012 and is headquartered in New Haven, Connecticut.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-60.65M
- Profit Margin
- 0.00%
- ROE (TTM)
- -153.84%
- EPS (Diluted)
- -214.01
- Book Value
- -34.73
Free newsletter
The Saturday TSX Wrap
The week on the TSX, in five minutes
- The biggest gainers and losers, and why they moved
- Sector and momentum moves at a glance
- The Canadian market stories you missed
Explore More
Common Questions About IRLA.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| SMX | SMX (Security Matters) Public Limited Company Class A Ordinary Shares | $19.25 | +105.88% |
| PEPG | PepGen Ltd | $4.61 | +92.89% |
| TTEC | TTEC Holdings Inc | $2.40 | +72.04% |
| NNOX | Nano X Imaging Ltd | $0.37 | +59.80% |
| TANH | Tantech Holdings Ltd | $30.56 | +58.01% |
| AACG | ATA Creativity Global | $0.89 | +52.14% |
| ESLA | Estrella Immunopharma Inc. | $0.75 | +45.40% |
| MNDO | MIND CTI Ltd | $1.26 | +44.83% |
Free with a Wealth Awesome account
Keep analysing IRLA, free
- Every WA Score, ranking and table
- Insider track records and SEDI filings
- Earnings history and analyst targets for every stock
Email only, no password, no card. Already a member? Use the same button to sign in.